Latest news
Telomir Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez - MoomooMoomoo · Tue, 04 Aug 2026 12:05:14 GMTTelomir Pharmaceuticals Inc (TELO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMTTelomir Pharmaceuticals Inc. (TELO) Q4 2025 Earnings: Wider-than-Expected Loss Amid Pre-Revenue R&D Stage - Profit Guidance Range - dars.gov.etdars.gov.et · Thu, 30 Jul 2026 13:37:14 GMTTelomir Pharmaceuticals (TELO) awards director 50,000 options at $1.34 exercise price - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) grants 50,000 stock options to director - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTelomir Pharmaceuticals (TELO) awards director 50,000 stock options at $1.34 - Stock TitanStock Titan · Mon, 27 Jul 2026 20:30:36 GMTTELO|Telomir Pharmaceuticals Inc|Price:1.210|Chg%:-0.040 - TradingKeyTradingKey · Mon, 27 Jul 2026 13:23:15 GMTTelomir Pharmaceuticals Inc (TELO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKeyTradingKey · Mon, 27 Jul 2026 00:16:30 GMT